Xiangyu Medical Co.,Ltd (SHA:688626)

Xiangyu Medical Co.,Ltd Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	764.03	733.63	736.61	483.87	515.8	491.24
Other Revenue	9.9	9.9	8.2	4.66	7.7	4.27
Revenue	773.93	743.53	744.81	488.53	523.5	495.51
Revenue Growth (YoY)	9.07%	-0.17%	52.46%	-6.68%	5.65%	15.93%
Cost of Revenue	260.9	252.61	243.35	170.08	169.57	162.69
Gross Profit	513.03	490.92	501.46	318.44	353.92	332.82
Selling, General & Admin	310.77	274.02	210.41	175.89	140.42	113.99
Research & Development	173.38	152.02	106.75	92.41	68.61	51.55
Other Operating Expenses	-10.82	-7.41	-9	-3.6	0.55	2.88
Operating Expenses	476.02	421.82	310.31	264.77	211.78	170.12
Operating Income	37.01	69.09	191.15	53.67	142.15	162.7
Interest Expense	-6.53	-3.63	-2.66	-0.19	-	-0.17
Interest & Investment Income	30.04	26.6	38.82	37.59	33.73	11.64
Currency Exchange Gain (Loss)	0.07	0.07	0.02	0.02	-0.02	0.06
Other Non Operating Income (Expenses)	-1.72	1.04	2.39	2.61	2.16	1.1
EBT Excluding Unusual Items	58.87	93.17	229.72	93.7	178.02	175.33
Gain (Loss) on Sale of Investments	-	-	-3.24	-1.06	-	-0.31
Gain (Loss) on Sale of Assets	0.08	0.07	0.01	-	-0.01	0.01
Asset Writedown	-0.65	-0.05	-0.02	-0.25	-	-0.14
Other Unusual Items	14.04	14.04	17.55	40.6	44.72	47.9
Pretax Income	72.34	107.24	244.03	132.99	222.72	222.79
Income Tax Expense	0.96	4.38	15.72	9.7	23.18	26.78
Earnings From Continuing Operations	71.38	102.85	228.31	123.3	199.54	196.01
Minority Interest in Earnings	2.13	0.09	-1.17	2.17	2.36	0.25
Net Income	73.51	102.94	227.14	125.47	201.9	196.26
Net Income to Common	73.51	102.94	227.14	125.47	201.9	196.26
Net Income Growth	-39.44%	-54.68%	81.03%	-37.85%	2.87%	52.17%
Shares Outstanding (Basic)	153	156	158	159	150	120
Shares Outstanding (Diluted)	153	156	158	159	150	120
Shares Change (YoY)	-2.83%	-1.12%	-0.68%	6.20%	24.97%	-0.72%
EPS (Basic)	0.48	0.66	1.44	0.79	1.35	1.64
EPS (Diluted)	0.48	0.66	1.44	0.79	1.35	1.64
EPS Growth	-37.68%	-54.17%	82.28%	-41.48%	-17.68%	53.27%
Free Cash Flow	-181.16	-260.3	-251.35	-16.37	31.97	76.69
Free Cash Flow Per Share	-1.19	-1.67	-1.59	-0.10	0.21	0.64
Dividend Per Share	0.240	0.240	0.530	0.240	0.380	0.370
Dividend Growth	-54.73%	-54.73%	120.90%	-36.84%	2.70%	-
Gross Margin	66.29%	66.03%	67.33%	65.18%	67.61%	67.17%
Operating Margin	4.78%	9.29%	25.66%	10.99%	27.15%	32.84%
Profit Margin	9.50%	13.84%	30.50%	25.68%	38.57%	39.61%
Free Cash Flow Margin	-23.41%	-35.01%	-33.75%	-3.35%	6.11%	15.48%
EBITDA	87.09	105.17	208.57	69.74	153.52	173.48
EBITDA Margin	11.25%	14.14%	28.00%	14.27%	29.33%	35.01%
D&A For EBITDA	50.08	36.08	17.41	16.06	11.37	10.78
EBIT	37.01	69.09	191.15	53.67	142.15	162.7
EBIT Margin	4.78%	9.29%	25.66%	10.99%	27.15%	32.84%
Effective Tax Rate	1.32%	4.09%	6.44%	7.29%	10.41%	12.02%
Revenue as Reported	773.93	743.53	744.81	488.53	523.5	495.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.